MC — Moelis & Company stock price, charts and financials

NYSE·Financial Services·Financial - Capital Markets·USA

Latest market price

64.10

-2.53-3.80%

Overview Short InterestFilings

MCQT37Moelis & Company·NYSE

Overview Short InterestFilings

64.10-3.80%

Loading chart...

Signal & projected range

Insider open-market saleHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

BGC+0.77%$10.43 FIGR-1.05%$28.32 MRX-0.71%$60.38 LAZ-2.10%$43.27 MIAX+1.54%$44.91 MKTX-0.02%$162.50 MARA-5.30%$9.55 GLXY-2.41%$19.68

Snapshot

Index	-	P/E	21.99	EPS (ttm)	3.03	Insider Own	6.96%	Shs Outstand	74.08M	Perf Week	-0.67%

Market Cap	4.94B	Forward P/E	16.86	EPS next Y	3.95	Insider Trans	-0.15%	Shs Float	73.33M	Perf Month	1.88%

Enterprise Value	4.99B	PEG	1.80	EPS next Q	0.74	Inst Own	-	Short Float	5.95%	Perf Quarter	4.26%

Income	223.60M	P/S	3.14	EPS this Y	8.75%	Inst Trans	-	Short Ratio	4.46	Perf Half Y	-7.05%

Sales	1.57B	P/B	9.95	EPS next Y	26.66%	ROA	16.21%	Short Interest	4.36M	Perf YTD	-3.07%

Book/sh	-	P/C	10.26	EPS next 5Y	9.56%	ROE	43.55%	52W High	75.25 -14.82%	Perf Year	-4.94%

Cash/sh	-	P/FCF	11.33	EPS past 3/5Y	11.17% -0.07%	ROIC	26.05%	52W Low	49.12 30.49%	Perf 3Y	39.10%

Dividend Est.	2.60 (4.06%)	EV/EBITDA	15.91	Sales past 3/5Y	15.48% 9.98%	Gross Margin	69.91%	Volatility	2.93% 3.69%	Perf 5Y	12.46%

Dividend TTM	1.95 (3.04%)	EV/Sales	3.17	EPS Y/Y TTM	61.24%	Oper. Margin	18.40%	ATR (14)	2.62	Perf 10Y	165.99%

Dividend Ex-Date	Aug 10, 2026	Quick Ratio	20.27	Sales Y/Y TTM	31.72%	Profit Margin	14.50%	RSI (14)	48.19	Recom	2.91

Dividend Gr. 3/5Y	2.70% -8.94%	Current Ratio	20.27	EPS Q/Q	18.87%	SMA20	-1.17%	Beta	1.81	Target Price	72.50

Payout	95.18%	Debt/Eq	0.52	Sales Q/Q	12.05%	SMA50	-1.09%	Rel Volume	0.80	Prev Close	66.63

Employees	1,416	LT Debt/Eq	0.35	Earnings	Nov 04	SMA200	1.10%	Avg Volume	930.02K	Price	64.10

IPO Date	Apr 16, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.10% 5.71%	Net Debt/EBITDA	0.18	Volume	745,084	Change	-3.80%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-30-26	Reiterated	Morgan Stanley	Overweight	$83 → $85
Jul-08-26	Downgrade	UBS	Neutral → Sell	$60
Apr-09-26	Reiterated	Morgan Stanley	Overweight	$92 → $83
Apr-08-26	Reiterated	UBS	Neutral	$74 → $58
Feb-05-26	Reiterated	BMO Capital		$75 → $78
Jan-20-26	Reiterated	Goldman Sachs	Neutral	$74 → $82
Jan-07-26	Reiterated	Wolfe Research	Underperform	$69 → $66
Jan-07-26	Reiterated	UBS	Neutral	$70 → $74
Dec-17-25	Downgrade	Keefe, Bruyette & Woods	Outperform → Market Perform
Dec-11-25	Reiterated	UBS	Sell	$30 → $70

Latest News

Jul-31-26

Jul-31-2603:51AM

Arrowstreet Capital Limited Partnership Makes New $15.62 Million Investment in Moelis & Company $MCdefenseworld.net

Jul-30-26

Jul-30-2601:34PM

Morgan Stanley Maintains Overweight on Moelis, Raises Price Target to $85Benzinga

10:16AM

Moelis & Company Q2 Earnings Beat Estimates on Higher Revenueszacks.com

01:05AM

Moelis & Company Q2 Earnings Call Highlightsmarketbeat.com

Jul-29-26

Jul-29-2610:33PM

Moelis & Company (MC) Q2 2026 Earnings Call Transcriptseekingalpha.com

09:09PM

Moelis & Co (NYSE:MC) Beats Q2 Revenue Estimates While EPS Matches ExpectationsChartMill

07:26PM

Moelis (MC) Q2 Earnings and Revenues Beat Estimateszacks.com

04:15PM

Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Sharebusinesswire.com

Jul-28-26

Jul-28-2610:51AM

Why Moelis (MC) is a Top Momentum Stock for the Long-Termzacks.com

Jul-24-26

Jul-24-2610:46AM

Here's Why Moelis (MC) is a Strong Growth Stockzacks.com

Jul-22-26

Jul-22-2611:02AM

Moelis (MC) Reports Next Week: Wall Street Expects Earnings Growthzacks.com

Jul-10-26

Jul-10-2612:41PM

EVR or MC: Which Is the Better Value Stock Right Now?zacks.com

Jul-09-26

Jul-09-2608:19AM

Moelis & Company: Downside Protectionseekingalpha.com

Jul-08-26

Jul-08-2604:53PM

UBS Downgrades Moelis (MC)Fintel

Jun-10-26

Jun-10-2604:02PM

Moelis & Company (MC) Presents at Morgan Stanley US Financials Conference 2026 TranscriptSeekingAlpha

Company

Moelis & Company operates as a dedicated investment banking advisory firm, offering expert counsel on a wide range of corporate finance matters. Its core services include strategic guidance for mergers and acquisitions (M&A), corporate recapitalizations and restructurings, and capital market transactions. The firm serves a diverse global client base, which encompasses large public multinational corporations, private middle-market businesses, financial sponsors, entrepreneurs, governmental organizations, and sovereign wealth funds. With operations spanning North and South America, Europe, the Middle East, Asia, and Australia, Moelis & Company also leverages strategic alliances, specifically with Alfaro, Dávila y Scherer, S.C. in Mexico and MA Moelis Australia. Founded in 2007, the company's headquarters are situated in New York, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	1,574	1,517	1,195	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	472	12	830	—	—	—	—	—	—
Gross Profit	1,100	1,505	364	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	703	30	108	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	108	1,201	83	—	—	—	—	—	—
Operating Income	289	274	173	—	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	52	54	23	—	—	—	—	—	—
Net Income Before Taxes	341	327	196	—	—	—	—	—	—
Income Taxes	85	68	45	—	—	—	—	—	—
Consolidated Net Income	228	233	136	—	—	—	—	—	—
Net Income From Continuing Operations	256	260	151	—	—	—	—	—	—
Net Income	228	233	136	—	—	—	—	—	—
EPS (Recurring)	3.03	3.11	1.89	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	3.03	3.11	1.89	—	—	—	—	—	—
EPS (Diluted)	2.87	2.94	1.78	—	—	—	—	—	—
EBITDA	313	339	183	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	22.33	23.38	41.51	—	—	—	—	—	—
Price To Sales Ratio	3.10	3.40	4.45	—	—	—	—	—	—
Gross Margin	69.89	99.21	30.46	—	—	—	—	—	—
Operating Margin	18.36	18.06	14.48	—	—	—	—	—	—
Net Margin	14.49	15.36	11.38	—	—	—	—	—	—
Shares Outstanding	76	75	72	—	—	—	—	—	—
Market Capitalization	4,872	5,156	5,319	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WATANABE OSAMU R.	General Counsel, Secretary	Aug 04 '26	Sale	69.30	4,850	336,105	131	Aug 06
Riehl Nick	Principal Accounting Officer	Feb 19 '26	Option Exercise	0.00	61	0	61	Feb 23
WATANABE OSAMU R.	General Counsel, Secretary	Feb 19 '26	Option Exercise	0.00	18,438	0	9,350	Feb 23
WATANABE OSAMU R.	General Counsel, Secretary	Feb 19 '26	Sale	62.23	2,765	172,066	4,981	Feb 23
Callesano Christopher	Chief Financial Officer	Feb 19 '26	Option Exercise	0.00	4,358	0	3,406	Feb 23
Pilcher Ciafone Katherine	Chief Operating Officer	Feb 19 '26	Option Exercise	0.00	9,771	0	8,819	Feb 23
Cantor Eric	Vice Chairman, MD	Feb 19 '26	Option Exercise	0.00	64,735	0	251,173	Feb 23
MOELIS KENNETH	Executive Chairman	Feb 18 '26	Option Exercise	0.00	847	0	4,190,479	Feb 20
Cantor Eric	Vice Chairman, MD	Dec 05 '25	Option Exercise	0.00	1,336	0	219,473	Dec 05
MOELIS KENNETH	Executive Chairman	Oct 30 '25	Option Exercise	0.00	133,165	0	4,191,326	Nov 03
Shropshire Kenneth	Director	Aug 22 '25	Sale	72.52	2,615	189,640	7,109	Aug 27
WATANABE OSAMU R.	General Counsel, Secretary	Jul 25 '25	Sale	72.64	6,340	460,538	131	Jul 29
MOELIS KENNETH	Chairman, CEO	Mar 07 '25	Option Exercise	0.00	3,750	0	4,324,418	Mar 07
Shropshire Kenneth	Director	Feb 21 '25	Sale	72.30	2,551	184,437	6,940	Feb 21
Pilcher Ciafone Katherine	Chief Operating Officer	Feb 19 '25	Option Exercise	0.00	14,902	0	7,451	Feb 21

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.